Levitas Bio
Unlocking a new dimension in cellular analysis
- Business Model
- B2B
- Website
- levitasbio.com
- Total Funding
- $18.0M
- Last Round
- $18.0M Series BJan 2021
- Rounds
- 1
About
LevitasBio develops a proprietary, label-free levitation platform for cellular analysis and sample preparation. Its technology enables researchers to recover higher-quality cells without bias, high pressure, or changes to gene-expression profiles. The approach is designed to preserve cell integrity and improve the quality and quantity of material available for downstream analysis.
Summary
Levitas Bio is a Biotech company. It has raised $18.0M in total across 1 round, most recently a $18.0M Series B round in Jan 2021.
Tech & App Stack
1 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jan 2021
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/levitas-bio"><img src="https://indexed.vc/api/badge/company/levitas-bio" alt="Levitas Bio on Indexed.vc" width="260" height="76" /></a>